Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.83
-0.16 (-2.29%)
At close: May 7, 2026

HKG:2566 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
138.41138.6119.7859.87119.41
Depreciation & Amortization
37.9136.2235.8235.7724.24
Other Amortization
6.660.720.32--
Loss (Gain) From Sale of Assets
0.070.270.410.040.33
Loss (Gain) From Sale of Investments
2.836.51.220.46-0.08
Stock-Based Compensation
5.555.311.930.180.15
Other Operating Activities
-4.3326.2426.6212.747.24
Change in Accounts Receivable
23.57-144.3-62.47-82.03-131.24
Change in Inventory
-6.9911.390.9127.7949.16
Change in Accounts Payable
21.38-15.42-9.22-14.8-32.69
Change in Unearned Revenue
-0.997.59-2.15-5.031.19
Change in Other Net Operating Assets
30.7921.6812.61-12.4129.83
Operating Cash Flow
254.8494.79135.7722.5667.53
Operating Cash Flow Growth
168.86%-30.19%501.82%-66.59%-
Capital Expenditures
-49.59-15.09-21.1-23.3-53.94
Sale of Property, Plant & Equipment
0.080.1200.010.05
Sale (Purchase) of Intangibles
-55.06-64.76-25.88-35.66-8.97
Investment in Securities
-300----
Investing Cash Flow
-404.57-79.73-46.98-58.94-62.86
Long-Term Debt Issued
114.9130.2143.31204.17209.62
Long-Term Debt Repaid
-136.07-176.55-196.16-170.3-158.65
Net Debt Issued (Repaid)
-21.17-46.35-52.8633.8850.97
Issuance of Common Stock
-521---
Common Dividends Paid
-13.73---12-
Other Financing Activities
-4.54-46.34-14.49-8.98-9.75
Financing Cash Flow
-39.45428.32-67.3512.8941.23
Foreign Exchange Rate Adjustments
0.221.080.210.2-0.12
Net Cash Flow
-188.96444.4521.64-23.2945.78
Free Cash Flow
205.2579.69114.66-0.7413.59
Free Cash Flow Growth
157.56%-30.50%---
Free Cash Flow Margin
15.71%5.82%8.91%-0.07%1.04%
Free Cash Flow Per Share
0.840.390.57-0.000.07
Cash Interest Paid
4.57.159.418.989.75
Cash Income Tax Paid
31.3719.16-1.1-10.511.74
Levered Free Cash Flow
83.8514.9112.11-51.21-
Unlevered Free Cash Flow
87.3919.3717.98-45.56-
Change in Working Capital
67.76-119.06-60.32-86.5-83.76
Source: S&P Global Market Intelligence. Standard template. Financial Sources.